In its March 2021 revised guidelines for lung cancer screening, the U.S. Preventive Services Task Force (USPTF) noted Black men have a higher incidence of lung cancer than white men, and Black women have a lower incidence than white women. Reasons for the disparity were likely prevalence of smoking and other social risk factors, the…
Patients with advanced/unresectable or metastatic breast cancer treated with palbociclib combination therapy experienced low levels of baseline pain and fatigue, a recent study found. The study is apparently one of the first outside a clinical trial to evaluate the day-to-day effects of advanced/unresectable or metastatic breast cancer and its treatment along with the effects of…
Sexual health is important for any adult’s well-being, but patients with cancer face a new set of challenges when it comes to sexuality. Laila S. Agrawal, M.D., breast cancer oncologist with Norton Cancer Institute, is spearheading efforts to develop a sexual health clinic at Norton Healthcare. “The World Health Organization says that sexual health is…
[vc_row][vc_column][vc_column_text]The Food and Drug Administration (FDA) recently approved Venclexta (venetoclax) as part of a non-chemotherapy treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy. Don A. Stevens, M.D., an oncologist at Norton Cancer Institute, was a pivotal investigator in…
A review of patients with midline tumors suggests shunting may be a more robust treatment for hydrocephalus in pediatric and adult patients with diffuse midline gliomas. Charts of 43 consecutive midline tumor patients were reviewed with approval from the Institutional Review Board (IRB) to determine the rate of hydrocephalus and the appropriate neurosurgical interventions. The…
As a neuro-oncologist with Norton Cancer Institute, Kaylyn Sinicrope, M.D., treats brain tumors and other neurological conditions related to cancer. Dr. Sinicrope said she was attracted to oncology by the deep doctor-patient relationships that are built and the opportunity to improve care for those with brain tumors in particular. “I see so many patients who…
Differentiating cancer from other unexplained masses, lumps or abnormalities can be quite complicated. It hinges on access to state-of-the-art testing, knowledgeable specialists who can make the right referral and follow-up, plus effective ongoing care. Norton Cancer Institute offers expedited access to advanced evaluation and diagnostic services from two community-based clinics. One is located in the…
John T. Hamm, M.D., director of Norton Cancer Institute’s research program and chairman of the Norton Hospital Cancer Committee, will lead the Quality of Care Council of the American Society of Clinical Oncology (ASCO). The Quality of Care Council provides strategic guidance on ASCO’s cancer quality activities, leadership in joint efforts with other societies and…
The latest colon cancer screening recommendations call for earlier screenings and include guidance to better reflect individual risks. The starting age for screening for the average person with no risk factors is now 45, five years earlier than the previous recommendations. A family history of polyps, colon cancer or inflammatory bowel disease pushes the recommended…
Clinical trials are vital tools in our fight against cancer. These have become an important link in determining the best new treatments and how therapies are best administered. In 2019, Norton Cancer Institute offered nearly 130 active clinical trials for cancers ranging from phase 1 to late-phase pivotal studies, and from first-line diagnoses to recurrent…
Projects to renovate Norton Cancer Institute – Downtown and create the nearby Women’s Cancer Center have been completed and the facilities are open. Norton Cancer Institute – Downtown (676 S. Floyd St.) This site houses our Prompt Care Clinics for patients with urgent care needs related to cancer, hepatitis C and sickle cell disease. Infusion…
Despite earlier detection efforts and improved treatment options, lung cancer remains the top cancer killer in the United States. According to Adam D. Lye, M.D., medical oncologist/hematologist with Norton Cancer Institute, the majority of lung cancer clinical trials there focus on non-small cell lung cancer, the most common form of lung cancer. “We’re working with…